OptiBiotix Health has appointed nutritional specialist Dr Frederic Narbel as the Managing Director of its prebiotics and SweetBiotix division. The company is focused on the human microbiome, and as such, Nardel’s expertise seems advantageous to the department.
Commenting on his appointment, Narbel said: “Prebiotics are an expanding area of microbiome science with the capability to revolutionise public health and combat consumer concerns over sugar intake and obesity. I look forward to working with OptiBiotix to raise the profile of Prebiotics and SweetBiotix and extend its use in a range of food and beverage applications on an international scale."
Precision engineered prebiotics, which modify specific elements of the human microbiome, are predicted to aid the development of new and novel solutions to help sustain a healthy lifestyle and reduce the risk of chronic illnesses such as diabetes and cardiovascular disease.
SweetBiotix, is a patented, natural, low-calorie fibre-based alternative to sugar. The SweetBiotix range includes both intense prebiotic sweeteners and bulk sugar substitutes, suitable for a wide range of sugar replacement applications in food and beverages.
Stephen O’Hara, CEO of OptiBiotix Health, added: “Dr Narbel is an exceptional business professional and we’re delighted to be working with him to engineer the success of SweetBiotix. His wealth of management experience and notable commitment to the nutrition industry bring a range of benefits to our business."
